Adma Biologics (ADMA) Capital Expenditures Growth (3y) (2016 - 2025)
Adma Biologics (ADMA) Capital Expenditures Growth (3y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -12.25% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 46.88% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 8.97% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Adma Biologics | 1.99 Bn | 1.91 Bn | 88.82 Mn | -33.87% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -33.87% |
| Sep 30, 2025 | 61.98% |
| Jun 30, 2025 | -14.97% |
| Mar 31, 2025 | 18.26% |
| Dec 31, 2024 | -9.14% |
| Sep 30, 2024 | -27.65% |
| Jun 30, 2024 | -22.72% |
| Mar 31, 2024 | -2.99% |
| Dec 31, 2023 | -30.71% |
| Sep 30, 2023 | -35.98% |
| Jun 30, 2023 | -40.64% |
| Mar 31, 2023 | -2.13% |
| Dec 31, 2022 | 32.97% |
| Sep 30, 2022 | 19.68% |
| Jun 30, 2022 | 207.72% |
| Mar 31, 2022 | 195.23% |
| Dec 31, 2021 | 64.95% |
| Sep 30, 2021 | 129.66% |
| Jun 30, 2021 | 108.03% |
| Mar 31, 2021 | 67.28% |